XOMA to Announce Third Quarter 2009 Financial Results and Host Conference Call on November 9 Nov 03, 2009 5:22pm EST
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management Oct 14, 2009 7:00am EDT
XOMA Announces Initiation of Its Phase 2 Clinical Program for XOMA 052 in Type 2 Diabetes and Cardiovascular Disease Oct 01, 2009 7:00am EDT
XOMA Presents Results Demonstrating Novel Mechanism of Action for XOMA 052 in Regulating IL-1 Beta Levels Sep 30, 2009 7:00am EDT
XOMA to Develop Therapeutic Antibody for H1N1 and H5N1 Influenza Viruses Under $2.2 Million U.S. Government Program Managed by SRI International Sep 23, 2009 3:00pm EDT
